语言下和口腔传递过敏原:针对口腔树突细胞进行过敏原特异性免疫疗法
概括
语言下免疫疗法 (SLIT) 提供了一个无针的过敏治疗替代方案. 通过辅助剂或纳米颗粒物增强对口腔树突细胞 (DC) 的过敏原传递,可以提高SLIT的有效性并减少所需的过敏原剂量.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 药物输送系统 药物输送系统
背景情况:
- 皮下免疫疗法 (SCIT) 涉及重复注射,并带有风险.
- 舌下免疫疗法 (SLIT) 是一种更安全,无针的替代方法来治疗过敏.
- 目前的SLIT需要比SCIT更高的过敏原剂量,因为缺乏辅助剂或专门的输送.
研究的目的:
- 审查影响亚语言/口腔过敏原输送的生理因素.
- 检查已批准的SLIT配方的治疗机制和临床开发.
- 为提高SLIT疗效,对辅助剂和输送系统进行分类.
主要方法:
- 对生理因素,机制和临床数据的文献综述.
- 对助剂和传递系统进行过敏原呈现的分析.
- 自然和合成产品的分类,用于下舌/口服.
主要成果:
- 语言下/口腔路线为局部和全身药物输送提供了优势.
- 辅助剂和输送系统可以提高过敏原对口腔树突细胞 (DC) 的可用性.
- 针对口服DCs可能会增加过敏原特异性免疫疗法 (AIT) 的有效性,同时减少剂量.
结论:
- 优化过敏原呈现平台是改善SLIT的关键.
- 辅助剂和传送系统,如纳米颗粒物,对AIT有希望.
- 对这些平台的进一步研究可能会导致更有效,更安全的过敏治疗方法.
相关概念视频
Drug Delivery: Miscellaneous Routes
925
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
925
Drug Delivery: Enteral Route
2.2K
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
2.2K
Allergic Reactions
33.2K
Overview
33.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.2K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.2K


